INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
80 hedge funds and large institutions have $125M invested in Infinity Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 30 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
43% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 21
Holders
80
Holding in Top 10
1
Calls
$536K
Puts
$368K
Top Buyers
| 1 | +$9.43M | |
| 2 | +$6.36M | |
| 3 | +$3.3M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.65M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.59M |
Top Sellers
| 1 | -$2.13M | |
| 2 | -$1.78M | |
| 3 | -$1.6M | |
| 4 |
Renaissance Technologies
New York
|
-$842K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$789K |